GlassScriptPhysician profile
Jason I Lifshutz
NPI 1215011960
$6,073.45
in general payments reported to CMS, 2019-2025
11 companies · $1,572 in 2025
The $1,572 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,015 · 2020: $186 · 2021: $783 · 2022: $1,626 · 2023: $539 · 2024: $352 · 2025: $1,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,298 · Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,297.58 |
| Food and Beverage | $1,166.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,937.73 | 2022-2025 | Cd Horizon Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology, Pivox Oblique Lateral Spinal System |
| Medtronic USA, INC. | $977.33 | 2019-2020 | |
| Providence Medical Technology, INC. | $805.32 | 2022-2025 | |
| Medical Device Business Services, INC. | $783.12 | 2021 | |
| Intrinsic Therapeutics | $241.60 | 2022 | |
| Zimmer Biomet Holdings, INC. | $118.99 | 2019 | |
| Si-Bone, INC. | $108.75 | 2019-2023 | |
| Depuy Synthes Sales INC. | $57.75 | 2023 | Sentio, Conduit |
| Integra Lifesciences Corporation | $16.22 | 2023 | Codman Certas, Codman Hakim, Cusa Clarity |
| Avanos Medical | $15.22 | 2023 | On-Q* Pump and Accessories |
| Stryker Corporation | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lifshutz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.